Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure
| Autor: | E. Junttila, A. Oscarsson-Tibblin, Anders Perner, Michael Haney, Casper Claudius, Morten Hylander Møller, A. Haavind |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
endocrine system
medicine.medical_specialty Anestesi och intensivvård First line Review Article 03 medical and health sciences Norepinephrine 0302 clinical medicine Medicine Humans Vasoconstrictor Agents 030212 general & internal medicine Acute circulatory failure Intensive care medicine Review Articles Anesthesiology and Intensive Care business.industry Critically ill Kirurgi 030208 emergency & critical care medicine Shock General Medicine Guideline Clinical Practice Anesthesiology and Pain Medicine Acute Disease Practice Guidelines as Topic Surgery business human activities hormones hormone substitutes and hormone antagonists |
| Zdroj: | Acta Anaesthesiologica Scandinavica Møller, M H, Claudius, C, Junttila, E, Haney, M, Oscarsson-Tibblin, A, Haavind, A & Perner, A 2016, ' Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure ', Acta Anaesthesiologica Scandinavica, vol. 60, no. 10, pp. 1347-1366 . https://doi.org/10.1111/aas.12780 |
| ISSN: | 1399-6576 |
| DOI: | 10.1111/aas.12780 |
| Popis: | BackgroundAdult critically ill patients often suffer from acute circulatory failure, necessitating use of vasopressor therapy. The aim of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) task force for Acute Circulatory Failure was to present clinically relevant, evidence-based treatment recommendations on this topic. MethodsThis guideline was developed according to standards for trustworthy guidelines, including a systematic review of the literature and use of the GRADE methodology for assessment of the quality of evidence and for moving from evidence to recommendations. We assessed the following subpopulations of patients with acute circulatory failure: 1) shock in general, 2) septic shock, 3) cardiogenic shock, 4) hypovolemic shock and 5) other types of shock, including vasodilatory shock. We assessed patient-important outcome measures, including mortality, serious adverse reactions and quality-of-life. ResultsFor patients with shock in general and those with septic shock, we recommend using norepinephrine rather than dopamine, and we suggest using norepinephrine rather than epinephrine, vasopressin analogues, and phenylephrine. For patients with cardiogenic shock and those with hypovolemic shock, we suggest using norepinephrine rather than dopamine, and we provide no recommendations/suggestions of norepinephrine vs. epinephrine, vasopressin analogues, and phenylephrine. For patients with other types of shock, including vasodilatory shock, we suggest using norepinephrine rather than dopamine, epinephrine, vasopressin analogues, and phenylephrine. ConclusionsWe recommend using norepinephrine rather than other vasopressors as first-line treatment for the majority of adult critically ill patients with acute circulatory failure. Funding Agencies|Scandinavian Society of Anaesthesiology and Intensive Care Medicine |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text